Towards Healthcare

Drug Discovery Informatics Companies, Corporate Growth and Development Strategy

Date : 23 February 2026

Explore Top Vendors in the Drug Discovery Informatics Market & Their Offering With Market Growth

Drug Discovery Informatics Market Companies are Certara, Boehringer Ingelheim International GmbH, Infosys Ltd.

Company Offerings

Companies Headquarters Offerings
Certara New Jersey, U.S Provides biosimulation and informatics platforms such as D360™ and Phoenix® to support compound data management, modeling, simulation, and data-driven decision-making across drug discovery and development. 
Boehringer Ingelheim International GmbH Ingelheim am Rhein, Germany Utilizes advanced informatics tools internally to integrate biological and chemical data, support translational research, and enhance efficiency across discovery and early development pipelines.
Infosys Ltd. Bengaluru, India Offers digital transformation, data analytics, and informatics services for life sciences, including lab informatics integration, data management solutions, and analytics platforms supporting drug discovery research.
Charles River Laboratories Massachusetts, U.S. Delivers integrated discovery and preclinical services supported by informatics-enabled platforms for data management, target validation, and accelerating target-to-IND workflows.
Collaborative Drug Discovery, Inc. (CDD) California, U.S. Develops CDD Vault, a cloud-based informatics platform that enables secure storage, analysis, and collaboration on chemical, biological, and assay data in drug discovery projects.
Eurofins DiscoverX Products California, U.S Provides cell-based assays, engineered cell lines, screening tools, and data solutions that integrate experimental results into drug discovery informatics workflows for target validation and profiling.

Value Chain Analysis

R&D

  • R&D in drug discovery informatics centers on using advanced computational technologies to streamline early-stage drug research. By combining intelligent algorithms with large-scale data analysis, these solutions help shorten discovery timelines, lower development expenses, and enhance the accuracy of preclinical outcomes.
  • Key players: Schrödinger, Certara, Thermo Fisher Scientific, Dassault Systèmes, and IBM.

Clinical Trials

  • Clinical trials informatics supports faster drug development by using advanced software and data-driven systems to handle complex clinical research activities. These tools streamline data collection and analysis across trial phases I–III, helping reduce high failure rates often linked to poor efficacy outcomes. Platforms such as Electronic Data Capture and analytics solutions improve data quality, patient safety, and regulatory readiness.
  • Key players: Oracle, Medidata (Dassault Systèmes), IQVIA, Veeva Systems, and Parexel.

Patient Support and Services

  • Patient support and services within drug discovery informatics focus on using digital platforms and data-driven tools to enhance patient engagement beyond traditional therapies. By incorporating real-world data, patient insights, and advanced analytics, these solutions improve treatment adherence, personalize care pathways, and inform research decisions earlier. This patient-centric approach helps speed development while improving outcomes.
  • Key players: IQVIA, Veeva Systems, Cognizant, Accenture, and PwC.

Market Growth

The global drug discovery informatics market size was estimated at USD 4.12 billion in 2025 and is predicted to increase from USD 4.6 billion in 2026 to approximately USD 12.39 billion by 2035, expanding at a CAGR of 11.64% from 2026 to 2035.

Drug Discovery Informatics Market Size is USD 4.6 Billion in 2026.

What are the Recent Developments in the Drug Discovery Informatics Market?

  • In April 2025, Revvity Signals Software introduced the Signals One platform to support faster drug discovery. The solution simplifies data management across different stages of the discovery process and helps researchers handle the growing complexity of diverse drug modalities more efficiently.
  • In February 2024, Aspen Biosciences introduced Pipeline, a drug discovery program management platform developed to support complex research workflows. The software is designed to efficiently handle large volumes of data, helping organizations better manage, track, and coordinate drug discovery projects.

Make smarter moves with all your Drug Discovery Informatics Market data under one roof - Access the Dashboard

WhatsApp